Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin for COVID-19 Prevention in Healthcare Workers
NCT04427865Phase 3Unknown
- Sponsor
- Cairo University
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 3, randomised, open-label trial of lactoferrin in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Cairo University. Primary endpoint: Incidence of SARS-CoV-2 at 28 days. Status: unknown.
02
Drugs
lactoferrin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04427865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04427865.